Geneos Wealth Management’s FT Vest US Equity Deep Buffer ETF October DOCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$179K Sell
3,837
-32
-0.8% -$1.47K ﹤0.01% 1030
2026
Q1
$168K Buy
3,869
+32
+0.8% +$1.42K ﹤0.01% 1018
2025
Q4
$170K Hold
3,837
﹤0.01% 972
2025
Q3
$166K Hold
3,837
﹤0.01% 962
2025
Q2
$158K Buy
3,837
+2,558
+200% +$99.8K ﹤0.01% 1084
2025
Q1
$49K Hold
1,279
﹤0.01% 1488
2024
Q4
$50.4K Buy
+1,279
New +$50.4K ﹤0.01% 1319

Other funds holding DOCT

Geneos Wealth Management's DOCT Position: Q2 2026 in Review

Geneos Wealth Management reduced its FT Vest US Equity Deep Buffer ETF October (DOCT) stake by 0.83% in Q2 2026, selling an estimated $1.47K and leaving 3,837 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #1030.

Geneos Wealth Management first reported a position in DOCT in Q4 2024 and has held it in 7 quarters since. 108 funds tracked by Wall St. Rank hold DOCT as of Q2 2026.

  • Geneos Wealth Management held 3,837 shares of FT Vest US Equity Deep Buffer ETF October worth $179K as of Q2 2026.
  • Geneos Wealth Management sold 32 FT Vest US Equity Deep Buffer ETF October shares in Q2 2026, an estimated $1.47K.
  • FT Vest US Equity Deep Buffer ETF October made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1030 holding.
  • Geneos Wealth Management first reported a position in FT Vest US Equity Deep Buffer ETF October in Q4 2024 and has held it in 7 quarters since.
  • 108 funds tracked by Wall St. Rank held FT Vest US Equity Deep Buffer ETF October as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.